tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ALKS Stock Latest News

Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
Weekend UpdatesAvidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
8d ago
RNA
ALKS
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
11d ago
COO
EOG
Alkermes upgraded to Buy from Neutral at UBS
PremiumThe Fly
Alkermes upgraded to Buy from Neutral at UBS
12d ago
ALKS
Alkermes presenting new research related to ALKS 2680 at SLEEP 2025
PremiumThe Fly
Alkermes presenting new research related to ALKS 2680 at SLEEP 2025
1M ago
ALKS
Alkermes initiated with a Buy at Needham
PremiumThe Fly
Alkermes initiated with a Buy at Needham
1M ago
ALKS
Alkermes Poised for Growth with Promising ALKS 2680 and Strategic Pipeline Expansion
PremiumRatingsAlkermes Poised for Growth with Promising ALKS 2680 and Strategic Pipeline Expansion
1M ago
ALKS
Alkermes Shareholders Approve Amendments at Annual Meeting
Premium
Company Announcements
Alkermes Shareholders Approve Amendments at Annual Meeting
1M ago
8K
ALKS
Alkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright
Premium
The Fly
Alkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright
2M ago
ALKS
Alkermes price target raised to $41 from $38 at Baird
PremiumThe Fly
Alkermes price target raised to $41 from $38 at Baird
2M ago
ALKS
Alkermes Hold Rating: Balancing Orexin Program Prospects and Competitive Risks
PremiumRatings
Alkermes Hold Rating: Balancing Orexin Program Prospects and Competitive Risks
2M ago
ALKS
Alkermes plc Reports Q1 2025 Financial Results
PremiumCompany Announcements
Alkermes plc Reports Q1 2025 Financial Results
2M ago
ALKS
Alkermes plc Earnings Call Highlights Growth and R&D Progress
PremiumCompany Announcements
Alkermes plc Earnings Call Highlights Growth and R&D Progress
2M ago
ALKS
Alkermes Inc.: Strong Buy Rating Driven by Robust Financial Performance and Promising Pipeline Potential
PremiumRatingsAlkermes Inc.: Strong Buy Rating Driven by Robust Financial Performance and Promising Pipeline Potential
2M ago
ALKS
Alkermes reports Q1 EPS 13c, consensus 24c
Premium
The Fly
Alkermes reports Q1 EPS 13c, consensus 24c
2M ago
ALKS
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ALKS
Alkermes price target lowered to $33 from $38 at UBS
PremiumThe Fly
Alkermes price target lowered to $33 from $38 at UBS
2M ago
ALKS
Balanced Assessment of Alkermes: Hold Rating Justified by Stable Valuation and Orexin Program Potential
PremiumRatings
Balanced Assessment of Alkermes: Hold Rating Justified by Stable Valuation and Orexin Program Potential
3M ago
ALKS
Alkermes initiates Phase 2 study evaluating ALKS 2680 in idopathic hypersomnia
PremiumThe Fly
Alkermes initiates Phase 2 study evaluating ALKS 2680 in idopathic hypersomnia
3M ago
ALKS
Alkermes price target raised to $52 from $40 at Deutsche Bank
PremiumThe Fly
Alkermes price target raised to $52 from $40 at Deutsche Bank
3M ago
ALKS
Alkermes price target raised to $35 from $34 at BofA
PremiumThe FlyAlkermes price target raised to $35 from $34 at BofA
3M ago
ALKS
Alkermes initiated with a Sector Perform at RBC Capital
Premium
The Fly
Alkermes initiated with a Sector Perform at RBC Capital
4M ago
ALKS
Alkermes upgraded to Neutral from Sell at UBS
Premium
The Fly
Alkermes upgraded to Neutral from Sell at UBS
4M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >